IFCB Official Journals

Cell Biology International

Cell Biology International has become a regular venue for papers from many different parts of the world, living up to its international status. In a changing era of electronic publishing, our publisher, Academic Press (a part of the Harcourtbrace empire), was taken over by Elsevier Science in 2001. At the end of 2002, it looked more like an Elsevier journal in style, and ScienceDirect is used instead of Idealibrary on the web. More of its operations are electronic, with far less dependency on hardcopy submissions (except for high quality photographs). One major advantage of publishing in CBI is that it is very catholic in its taste, and publishes on any type of cell, including plant and protozoa, provided the content is made relevant to cell biology in general. Our services offered through "BioMedES" www.biomedes.com are there to assist authors from all parts of the world in publishing their work in the best possible light in the official journal of the International Federation for Cell Biology.

One matter worth emphasising here is the contribution of CBI to IFCB. As CBI increases in scope, size and status amongst cell biology journals, its revenue increases. Any profit that comes our way after the publishers have taken their percentage is ploughed back into the IFCB. It goes to keep our operations alive, which includes the support of workshops, symposia, special lectures, congresses and travel award to major meetings. We encourage you to subscribe and submit to CBI in order that we can boost this income and in turn help international cell biology even more in the future. Under a WHO initiative, we also hope that people in some of the disadvantaged economies in the world will be given easy and free access to our journal.

We encourage you to subscribe and submit to CBI in order that we can boost this income and in turn help international cell biology even more in the future.

Cancer Cell International

Cancer Cell International is a new journal which is entirely on-line, with free access to all. It is published by BioMed Central (London). It takes paper that are specifically dealing with the cancer cells, their cell biology and behaviour mainly in vitro. It deliberately avoids papers with a clinical bent, and will not take articles on experimental tumour work in animals unless this is also an integral part of cell biology studies on cultured cancer cells. Authors load their manuscripts directly on to the BMC website where they are dealt with on private pages until accepted, at which time they go on-line. The whole process is the modus operandi of publishing in the future. It is technically possible to get a publication through peer review and on-line within about a working day. If you have papers on cancer cells, do consider this site.